John Greene Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for John Greene.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of John Greene. John Greene is a in WILLIS TOWERS WATSON PLC ($WSH) and a Chief Financial Officer in WILLIS TOWERS WATSON PLC ($WSH) and a EVP & Chief Financial Officer in Discover Financial Services ($DFS) and a EVP, CFO and Treasurer in Bioverativ Inc. ($BIVV) and a Director in CRISPR Therapeutics AG ($CRSP).
Address: C/O WILLIS GROUP HOLDINGS PLC 51 LIME STREET LONDON, ENGLAND EC3M 7DQUnited Kingdom
Companies in which John Greene is an Insider
Bioverativ Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of John Greene: EVP, CFO and Treasurer
Holdings: 0 shares
Current Value: $0
Latest Transaction: Mar 08 2018
$BIVV Market Capitalization: $4637.62B
$BIVV Previous Close: $44.44
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
CRISPR Therapeutics AG
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of John Greene: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jun 15 2020
$CRSP Market Capitalization: $605.88M
$CRSP Previous Close: $15.75
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Discover Financial Services
Industry: PERSONAL CREDIT INSTITUTIONS [6141]
Position of John Greene: EVP & Chief Financial Officer
Holdings: 34,887 shares
Current Value: $2,390,108
Latest Transaction: Feb 23 2021
$DFS Market Capitalization: $26.51B
$DFS Previous Close: $68.51
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
WILLIS TOWERS WATSON PLC
Industry: INSURANCE AGENTS BROKERS & SERVICES [6411]
Position of John Greene:
Holdings: 14,805 shares
Latest Transaction: Jan 06 2016
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of John Greene
Sentiment: All, BIVV, CRSP, DFS, WSH
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 23 2021 | DFS | Discover Financial ... | Greene John | EVP & Chief Financi ... | Grant | A | 0.00 | 9,690 | 0 | 34,887 | 44.6 K to 34.9 K (-21.74 %) |
| Feb 03 2021 | DFS | Discover Financial ... | Greene John | EVP & Chief Financi ... | Payment of Exercise | F | 82.19 | 1,146 | 94,190 | 25,197 | 26.3 K to 25.2 K (-4.35 %) |
| Aug 03 2020 | DFS | Discover Financial ... | Greene John | EVP & Chief Financi ... | Payment of Exercise | F | 49.43 | 1,159 | 57,289 | 26,343 | 27.5 K to 26.3 K (-4.21 %) |
| Jun 15 2020 | CRSP | CRISPR Therapeutic ... | Greene John | Director | Option Exercise | A | 59.70 | 15,000 | 895,500 | 15,000 | |
| Jan 27 2020 | DFS | Discover Financial ... | Greene John | EVP & Chief Financi ... | Buy | P | 73.84 | 3,377 | 249,343 | 27,502 | 24.1 K to 27.5 K (+14.00 %) |
| Jan 24 2020 | DFS | Discover Financial ... | Greene John | EVP & Chief Financi ... | Grant | A | 0.00 | 11,198 | 0 | 24,125 | 12.9 K to 24.1 K (+86.62 %) |
| Sep 20 2019 | DFS | Discover Financial ... | Greene John | EVP & Chief Financi ... | Grant | A | 0.00 | 11,861 | 0 | 12,927 | 1.1 K to 12.9 K (+1,112.66 %) |